Price
$2.87
Decreased by -2.05%
Dollar volume (20D)
1.81 M
ADR%
7.59
Earnings report date
Aug 8, 2024
Shares float
32.42 M
Shares short
990.38 K [3.06%]
Shares outstanding
60.08 M
Market cap
176.03 M
Beta
0.10
Price/earnings
N/A
20D range
2.08 3.20
50D range
2.08 3.92
200D range
1.81 5.09

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease.

The company focuses on advancing a targeted immunotherapy drug candidate sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2 that completed Phase I clinical trial to target soluble amyloid-beta oligomers.

The company has a license agreement with Lonza Sales AG to manufacture and commercialize sabirnetug; and a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of sabirnetug.

Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 14, 24 -0.25
Increased by +10.71%
-0.26
Increased by +3.85%
Mar 26, 24 -0.28
Increased by +12.50%
-0.26
Decreased by -7.69%
Nov 13, 23 -0.24
Increased by +7.69%
-0.27
Increased by +11.11%
Aug 8, 23 -0.28
Decreased by -12.00%
-0.35
Increased by +20.00%
May 9, 23 -0.28
Decreased by -21.74%
-0.35
Increased by +20.00%
Mar 27, 23 -0.32
Increased by +23.81%
-0.25
Decreased by -28.00%
Nov 14, 22 -0.26
Decreased by -160.00%
-0.23
Decreased by -13.04%
Aug 15, 22 -0.25
Increased by +96.84%
-0.24
Decreased by -4.17%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 24 N/A
Decreased by N/A%
-14.87 M
Decreased by -56.90%
- -
Dec 31, 23 290.00 K
Increased by +N/A%
-16.50 M
Decreased by -18.99%
Decreased by -5.69 K%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-12.96 M
Decreased by -28.94%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-11.61 M
Decreased by -17.38%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-9.48 M
Decreased by -4.72%
Decreased by N/A%
Decreased by N/A%
Dec 31, 22 0.00
Decreased by N/A%
-13.86 M
Decreased by -66.06%
Decreased by N/A%
Decreased by N/A%
Sep 30, 22 0.00
Decreased by N/A%
-10.05 M
Decreased by -157.53%
Decreased by N/A%
Decreased by N/A%
Jun 30, 22 0.00
Decreased by N/A%
-9.89 M
Increased by +83.88%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY